Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amnon Peled

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
EMBO Molecular Medicine|July 5, 2022
Single-cell transcriptomics reveals a senescence-associated IL-6/CCR6 axis driving radiodermatitisMor Paldor, Orr Levkovitch-Siany, Dana Eidelshtein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2013
The high-affinity CXCR4 antagonist BKT140 is safe and induces a robust mobilization of human CD34+ cells in patients with multiple myelomaAmnon Peled, Michal Abraham, Irit Avivi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2015
In the hunt for therapeutic targets: mimicking the growth, metastasis, and stromal associations of early-stage lung cancer using a novel orthotopic animal modelIdo D Weiss, Ezra Ella, Omri Dominsky, et al.
The Journal of Investigative Dermatology|December 31, 2005
Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burnsShani Avniel, Zaretski Arik, Alex Maly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
IFN-gamma acts on T cells to induce NK cell mobilization and accumulation in target organsOri Wald, Ido D Weiss, Hanna Wald, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 13, 2018
Matrix metalloproteinase 12 promotes tumor propagation in the lungEzra Ella, Yaniv Harel, Michal Abraham, et al.
Bone Marrow Transplantation|May 21, 2020
Brief ex vivo Fas-ligand incubation attenuates GvHD without compromising stem cell graft performanceHilit Levy-Barazany, Liat Shachnai-Pinkas, Galina Rodionov, et al.
Molecular Cancer Therapeutics|January 24, 2026
DSP502 combines dual inhibition of PD-L1 and PVR to trigger anti-cancer immune responsesVinicio A Melo Gallegos, Shirley Greenwald, Ami Tamir, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 15, 2022
DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunityEwa Cendrowicz, Lisa Jacob, Shirley Greenwald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 TrialBruno Bockorny, Teresa Macarulla, Valerya Semenisty, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
EMBO Molecular Medicine|July 5, 2022
Single-cell transcriptomics reveals a senescence-associated IL-6/CCR6 axis driving radiodermatitisMor Paldor, Orr Levkovitch-Siany, Dana Eidelshtein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2013
The high-affinity CXCR4 antagonist BKT140 is safe and induces a robust mobilization of human CD34+ cells in patients with multiple myelomaAmnon Peled, Michal Abraham, Irit Avivi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2015
In the hunt for therapeutic targets: mimicking the growth, metastasis, and stromal associations of early-stage lung cancer using a novel orthotopic animal modelIdo D Weiss, Ezra Ella, Omri Dominsky, et al.
The Journal of Investigative Dermatology|December 31, 2005
Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burnsShani Avniel, Zaretski Arik, Alex Maly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
IFN-gamma acts on T cells to induce NK cell mobilization and accumulation in target organsOri Wald, Ido D Weiss, Hanna Wald, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 13, 2018
Matrix metalloproteinase 12 promotes tumor propagation in the lungEzra Ella, Yaniv Harel, Michal Abraham, et al.
Bone Marrow Transplantation|May 21, 2020
Brief ex vivo Fas-ligand incubation attenuates GvHD without compromising stem cell graft performanceHilit Levy-Barazany, Liat Shachnai-Pinkas, Galina Rodionov, et al.
Molecular Cancer Therapeutics|January 24, 2026
DSP502 combines dual inhibition of PD-L1 and PVR to trigger anti-cancer immune responsesVinicio A Melo Gallegos, Shirley Greenwald, Ami Tamir, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 15, 2022
DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunityEwa Cendrowicz, Lisa Jacob, Shirley Greenwald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 TrialBruno Bockorny, Teresa Macarulla, Valerya Semenisty, et al.
Pageof 9